| Year |
Citation |
Score |
| 2014 |
Perez F, Arias CA, Bush K, Drusano GL, Lolans K, Munoz-Price LS, Nicolau DP, Queenan AM, Rice LB, Segreti J, Shlaes DM, Weinstein RA, Bonomo RA. In memoriam: John P. Quinn, MD. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 748-50. PMID 24336826 DOI: 10.1093/Cid/Cit801 |
0.329 |
|
| 2014 |
Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, Messonnier N, Tondella ML. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clinical and Vaccine Immunology : Cvi. 21: 119-25. PMID 24256623 DOI: 10.1128/Cvi.00717-13 |
0.324 |
|
| 2013 |
Bush K, Pannell M, Lock JL, Queenan AM, Jorgensen JH, Lee RM, Lewis JS, Jarrett D. Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. International Journal of Antimicrobial Agents. 41: 1-4. PMID 23219246 DOI: 10.1016/J.Ijantimicag.2012.08.008 |
0.325 |
|
| 2012 |
Queenan AM, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010. Diagnostic Microbiology and Infectious Disease. 73: 267-70. PMID 22579652 DOI: 10.1016/J.Diagmicrobio.2012.04.002 |
0.335 |
|
| 2012 |
Fernandez J, Abbanat D, Shang W, He W, Amsler K, Hastings J, Queenan AM, Melton JL, Barron AM, Flamm RK, Lynch AS. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56: 1476-84. PMID 22232278 DOI: 10.1128/Aac.06057-11 |
0.303 |
|
| 2011 |
Morrow BJ, Abbanat D, Baum EZ, Crespo-Carbone SM, Davies TA, He W, Shang W, Queenan AM, Lynch AS. Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2. Antimicrobial Agents and Chemotherapy. 55: 5512-21. PMID 21911562 DOI: 10.1128/Aac.00470-11 |
0.332 |
|
| 2011 |
Snydman DR, Jacobus NV, McDermott LA, Golan Y, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rosenblatt J, Venezia R, Gorbach SL, Queenan AM, Hecht DW. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe. 17: 147-51. PMID 21664469 DOI: 10.1016/J.Anaerobe.2011.05.014 |
0.336 |
|
| 2010 |
Queenan AM, Shang W, Bush K, Flamm RK. Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole. Antimicrobial Agents and Chemotherapy. 54: 4092-7. PMID 20606064 DOI: 10.1128/Aac.00060-10 |
0.32 |
|
| 2010 |
Queenan AM, Shang W, Flamm R, Bush K. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrobial Agents and Chemotherapy. 54: 565-9. PMID 19884379 DOI: 10.1128/Aac.01004-09 |
0.331 |
|
| 2009 |
Baum EZ, Crespo-Carbone SM, Morrow BJ, Davies TA, Foleno BD, He W, Queenan AM, Bush K. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53: 2785-90. PMID 19433554 DOI: 10.1128/Aac.00018-09 |
0.433 |
|
| 2008 |
Schneider I, Keuleyan E, Rasshofer R, Markovska R, Queenan AM, Bauernfeind A. VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany. Antimicrobial Agents and Chemotherapy. 52: 2977-9. PMID 18519714 DOI: 10.1128/Aac.00175-08 |
0.366 |
|
| 2008 |
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy (2001) 45, 4, (1151-1161)) Antimicrobial Agents and Chemotherapy. 52: 809. DOI: 10.1128/Aac.01445-07 |
0.318 |
|
| 2007 |
Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Reviews. 20: 440-58, table of con. PMID 17630334 DOI: 10.1128/Cmr.00001-07 |
0.356 |
|
| 2007 |
Queenan AM, Shang W, Kania M, Page MG, Bush K. Interactions of ceftobiprole with beta-lactamases from molecular classes A to D. Antimicrobial Agents and Chemotherapy. 51: 3089-95. PMID 17591851 DOI: 10.1128/Aac.00218-07 |
0.336 |
|
| 2006 |
Queenan AM, Shang W, Schreckenberger P, Lolans K, Bush K, Quinn J. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. Antimicrobial Agents and Chemotherapy. 50: 3485-7. PMID 17005839 DOI: 10.1128/Aac.00363-06 |
0.384 |
|
| 2006 |
Fakioglu E, Queenan AM, Bush K, Jenkins SG, Herold BC. Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge. Journal of Perinatology : Official Journal of the California Perinatal Association. 26: 515-7. PMID 16871223 DOI: 10.1038/Sj.Jp.7211550 |
0.385 |
|
| 2006 |
Schneider I, Queenan AM, Bauernfeind A. Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa. Antimicrobial Agents and Chemotherapy. 50: 1330-5. PMID 16569848 DOI: 10.1128/Aac.50.4.1330-1335.2006 |
0.359 |
|
| 2006 |
Villegas MV, Lolans K, del Rosario Olivera M, Suarez CJ, Correa A, Queenan AM, Quinn JP. First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Antimicrobial Agents and Chemotherapy. 50: 226-9. PMID 16377690 DOI: 10.1128/Aac.50.1.226-229.2006 |
0.385 |
|
| 2006 |
Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. The Journal of Antimicrobial Chemotherapy. 57: 24-30. PMID 16319181 DOI: 10.1093/Jac/Dki429 |
0.379 |
|
| 2005 |
Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. Antimicrobial Agents and Chemotherapy. 49: 3538-40. PMID 16048978 DOI: 10.1128/Aac.49.8.3538-3540.2005 |
0.306 |
|
| 2004 |
Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Journal of Clinical Microbiology. 42: 269-75. PMID 14715764 DOI: 10.1128/Jcm.42.1.269-275.2004 |
0.396 |
|
| 2003 |
Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrobial Agents and Chemotherapy. 47: 3881-9. PMID 14638498 DOI: 10.1128/Aac.47.12.3881-3889.2003 |
0.419 |
|
| 2003 |
Materon IC, Queenan AM, Koehler TM, Bush K, Palzkill T. Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 47: 2040-2. PMID 12760895 DOI: 10.1128/Aac.47.6.2040-2042.2003 |
0.424 |
|
| 2002 |
Rasheed JK, Anderson GJ, Queenan AM, Biddle JW, Oliver A, Jacoby GA, Bush K, Tenover FC. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 46: 2000-3. PMID 12019125 DOI: 10.1128/Aac.46.6.2000-2003.2002 |
0.373 |
|
| 2002 |
Wong-Beringer A, Hindler J, Loeloff M, Queenan AM, Lee N, Pegues DA, Quinn JP, Bush K. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 135-46. PMID 11740699 DOI: 10.1086/324742 |
0.338 |
|
| 2001 |
Queenan AM, Jenkins S, Bush K. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrobial Agents and Chemotherapy. 45: 3189-94. PMID 11600376 DOI: 10.1128/Aac.45.11.3189-3194.2001 |
0.399 |
|
| 2001 |
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 45: 1151-61. PMID 11257029 DOI: 10.1128/Aac.45.4.1151-1161.2001 |
0.431 |
|
| 2000 |
Urban C, Mariano N, Rahman N, Queenan AM, Montenegro D, Bush K, Rahal JJ. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins. Microbial Drug Resistance (Larchmont, N.Y.). 6: 297-303. PMID 11272258 DOI: 10.1089/Mdr.2000.6.297 |
0.366 |
|
| 2000 |
Queenan AM, Torres-Viera C, Gold HS, Carmeli Y, Eliopoulos GM, Moellering RC, Quinn JP, Hindler J, Medeiros AA, Bush K. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrobial Agents and Chemotherapy. 44: 3035-9. PMID 11036019 DOI: 10.1128/Aac.44.11.3035-3039.2000 |
0.372 |
|
| 2000 |
Rasheed JK, Anderson GJ, Yigit H, Queenan AM, Doménech-Sánchez A, Swenson JM, Biddle JW, Ferraro MJ, Jacoby GA, Tenover FC. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrobial Agents and Chemotherapy. 44: 2382-8. PMID 10952583 DOI: 10.1128/Aac.44.9.2382-2388.2000 |
0.375 |
|
| 1999 |
Queenan AM, Barcelo G, Van Buskirk C, Schüpbach T. The transmembrane region of Gurken is not required for biological activity, but is necessary for transport to the oocyte membrane in Drosophila. Mechanisms of Development. 89: 35-42. PMID 10559478 DOI: 10.1016/S0925-4773(99)00196-3 |
0.607 |
|
| 1997 |
Queenan AM, Ghabrial A, Schüpbach T. Ectopic activation of torpedo/Egfr, a Drosophila receptor tyrosine kinase, dorsalizes both the eggshell and the embryo. Development (Cambridge, England). 124: 3871-80. PMID 9367443 |
0.617 |
|
| Show low-probability matches. |